RxDoctor Payments Data

Chandler Myers

Women's Health · Belpre, OHNPI 1982072054

Payments from drug & device makers

$878in general payments, 2019–2025

Across 34 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$136
  • Genmab U.S., Inc.$133
  • Pfizer$102
  • Astellas Pharma US Inc$99
  • AVEO Pharmaceuticals, Inc.$64
  • Bristol Myers Squibb$61
  • plus $282 from 12 others

What the payments were for

  • Food & beverage$65274%
  • Education$22526%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$878 in reported general payments places this provider in the 75th percentile of 333 women's health providers in Ohio.

See all women's health providers in Ohio

Medicare billing

Part B allowed, 2024
$33,856
Medicare patients
290
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$27,423
XareltoRivaroxaban18$11,175
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$447
Ondansetron Hcl29$395
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$282
Oxycodone Hcl12$250
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$212
Prochlorperazine Maleate18$203
Olanzapine17$197
Acyclovir11$172
Nystatin14$163
Letrozole12$154
Gabapentin14$140
Potassium Chloride13$132
Trazodone Hcl17$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$102$27,42340 claims
Johnson & JohnsonXarelto$14$11,17518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 333 women's health providers in Ohio.

Other women's health in Belpre

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →